Transfusion reductions seen with stem cell gene therapy for beta-thalassemia June 1, 2018 No Comments
Astellas and FibroGen announce topline data from Japanese phase III study of roxadustat June 1, 2018 No Comments
Doptelet becomes available in the U.S. for the treatment of thrombocytopenia June 1, 2018 No Comments
Portola Pharmaceuticals receives milestone payment following Andexxa approval May 25, 2018 No Comments
FDA accepts supplemental BLA and grants priority review for pediatric use of Coagadex May 24, 2018 No Comments
RSS